APA (7th ed.) Citation

Campo, G., Tebaldi, M., Vranckx, P., Biscaglia, S., Tumscitz, C., Ferrari, R., & Valgimigli, M. (2014). Short- Versus Long-Term Duration of Dual Antiplatelet Therapy in Patients Treated for In-Stent Restenosis: A PRODIGY Trial Substudy (Prolonging Dual Antiplatelet Treatment After Grading Stent-Induced Intimal Hyperplasia). Journal of the American College of Cardiology (JACC), 63(6), 506. https://doi.org/10.1016/j.jacc.2013.09.043

Chicago Style (17th ed.) Citation

Campo, Gianluca, Matteo Tebaldi, Pascal Vranckx, Simone Biscaglia, Carlo Tumscitz, Roberto Ferrari, and Marco Valgimigli. "Short- Versus Long-Term Duration of Dual Antiplatelet Therapy in Patients Treated for In-Stent Restenosis: A PRODIGY Trial Substudy (Prolonging Dual Antiplatelet Treatment After Grading Stent-Induced Intimal Hyperplasia)." Journal of the American College of Cardiology (JACC) 63, no. 6 (2014): 506. https://doi.org/10.1016/j.jacc.2013.09.043.

MLA (9th ed.) Citation

Campo, Gianluca, et al. "Short- Versus Long-Term Duration of Dual Antiplatelet Therapy in Patients Treated for In-Stent Restenosis: A PRODIGY Trial Substudy (Prolonging Dual Antiplatelet Treatment After Grading Stent-Induced Intimal Hyperplasia)." Journal of the American College of Cardiology (JACC), vol. 63, no. 6, 2014, p. 506, https://doi.org/10.1016/j.jacc.2013.09.043.